News

Zacks.com on MSN4h
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet
Key Points Canopy Growth seems unable to overcome the industrywide challenges it faces.Novavax's recent quarterly update, though strong, says little about its prospects. 10 stocks we like better than ...